Helus Pharma: An Undervalued Psychedelic Platform Approaching A Major Catalyst

This article was written by Follow Richard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the result of a poor understanding of a businesses long-term prospects. Narweena believes that excess risk adjusted returns can be achieved by identifying businesses with secular growth opportunities in markets with barriers [...] The post Helus Pharma: An…